Callitas Health Signs Product Development and Manufacturing Agreement with LifeStyles
February 13, 2019 08:30 ET
|
Callitas Health Inc.
CINCINNATI, OH, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) a diversified clinical-stage...
Callitas Health Signs Letter of Intent with NuEthix, LLC to Supply CannaStrip Technology in Nutrition and Fitness Segment
February 07, 2019 08:30 ET
|
Callitas Health Inc.
CINCINNATI, OH, Feb. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”), an integrated clinical-stage...
Callitas Health, Inc. Releases End-of-Year Update Letter to Shareholders
December 19, 2018 08:00 ET
|
Callitas Health Inc.
CINCINNATI, OH, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F3), today announced that President and Chief Executive Officer, James...
Callitas Health Announces Passing of Former CEO and President Gary A. Thompson
September 13, 2018 18:13 ET
|
Callitas Health Inc.
CINCINNATI, OH, Sept. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) announced today with great sadness,...
Callitas Health Signs Letter of Intent with Lifestyles to Supply Unique Finished Goods for Retail Sale
August 14, 2018 08:30 ET
|
Callitas Health Inc.
CINCINNATI, OH, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development...
Callitas Health, Inc. Receives Full US Patent Grant for Treatment for Male Infertility (and Sub-Fertility)
July 25, 2018 08:30 ET
|
Callitas Health Inc.
CINCINNATI, OH, July 25, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
Callitas Health Launches Affiliate Network to Expand Reach for ToConceive
July 10, 2018 08:30 ET
|
Callitas Health Inc.
CINCINNATI, OH, July 10, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
Callitas Health, Inc. Signs Non-Exclusive Licensing Agreement for Patented Arousal Gel Technology & Products with LifeStyles, LTD
June 26, 2018 08:30 ET
|
Callitas Health Inc.
CINCINNATI, OH & SOUTH ISELIN, NJ, June 26, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical...
James Thompson Elevated to President and Chief Executive Officer of Callitas Health, Inc.
June 07, 2018 08:30 ET
|
Callitas Health Inc.
CINCINNATI, OH, June 07, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC...
Dr. Gregory Smith MD, MPH, Chief Medical Cannabis Advisor for Callitas Health, Releases New Book on THCV
June 05, 2018 10:32 ET
|
Callitas Health Inc.
CINCINNATI, OH, June 05, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC...